Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial-Reference-Cited by-同舟云学术

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

Published:2016-05 Issue:10031 Volume:387 Page:1909-1920
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rosenberg Jonathan E,Hoffman-Censits Jean,Powles Tom,van der Heijden Michiel S,Balar Arjun V,Necchi Andrea,Dawson Nancy,O'Donnell Peter H,Balmanoukian Ani,Loriot Yohann,Srinivas Sandy,Retz Margitta M,Grivas Petros,Joseph Richard W,Galsky Matthew D,Fleming Mark T,Petrylak Daniel P,Perez-Gracia Jose Luis,Burris Howard A,Castellano Daniel,Canil Christina,Bellmunt Joaquim,Bajorin Dean,Nickles Dorothee,Bourgon Richard,Frampton Garrett M,Cui Na,Mariathasan Sanjeev,Abidoye Oyewale,Fine Gregg D,Dreicer Robert

Funder

NIH/NCI Cancer Center Support

Publisher

Elsevier BV

Subject

General Medicine

Reference49 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J Urol,1976

4. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

5. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986;De Santis;J Clin Oncol,2012

Cited by 3101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor;Clinical Genitourinary Cancer;2024-12

2. Research Progress of PD 1/PD L1 Inhibitors in the Treatment of Urological Tumors;Current Cancer Drug Targets;2024-11

3. Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer;Urologic Oncology: Seminars and Original Investigations;2024-11

4. Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy;International Journal of Biological Macromolecules;2024-10

5. Double agents in immunotherapy: Unmasking the role of antibody drug conjugates in immune checkpoint targeting;Critical Reviews in Oncology/Hematology;2024-10